Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | COMT | P21964 | 1/20 | 0.41 |
| ▸ | AOC2 | O75106 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15021470 | 0.90 | GAA (0.51) | FFAR4MAPTGAACOMTAOC2 | |
| SCHEMBL15021167 | 0.85 | NPC1 (0.42) | FFAR4MAPTGAAALDH1A1MEN1 | |
| SCHEMBL27479253 | 0.82 | COMT (0.54) | FFAR4MAPTGAACOMTAOC2 | |
| SCHEMBL15021542 | 0.82 | MEN1 (0.58) | MAPTMEN1KMT2AHTTLMNA | |
| SCHEMBL10498584 | 0.79 | GAA (0.46) | FFAR4MAPTGAACOMTAOC2 | |
| SCHEMBL6984637 | 0.79 | RAB9A (0.54) | MAPTGAAAOC2ALDH1A1MEN1 | |
| SCHEMBL26369966 | 0.77 | ERCC1 (0.47) | FFAR4MAPTGAAALDH1A1HTT | |
| SCHEMBL15021326 | 0.76 | ERCC1 (0.52) | FFAR4MAPTALDH1A1HTTMGLL | |
| SCHEMBL17029433 | 0.75 | HTR7 (0.51) | MAPTGAAALDH1A1MEN1HPGD | |
| SCHEMBL15022221 | 0.74 | CYP19A1 (0.42) | MAPTGAAAOC2ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9115119-B2 | Electron transport material and organic light emitting device | AU OPTRONICS CORPORATION (TW) | 2015-08-25 | — | — | US | disclosed |
| US-9115119-B2 | Electron transport material and organic light emitting device | AU OPTRONICS CORPORATION (TW) | 2015-08-25 | — | — | US | disclosed |
| US-9115119-B2 | Electron transport material and organic light emitting device | AU OPTRONICS CORPORATION (TW) | 2015-08-25 | — | — | US | disclosed |
| US-20130153863-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC LIGHT EMITTING DEVICE | AU OPTRONICS CORPORATION (TW) | 2013-06-20 | — | — | US | disclosed |
| US-20130153863-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC LIGHT EMITTING DEVICE | AU OPTRONICS CORPORATION (TW) | 2013-06-20 | — | — | US | disclosed |
| US-20130153863-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC LIGHT EMITTING DEVICE | AU OPTRONICS CORPORATION (TW) | 2013-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130153863-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC LIGHT EMITTING DEVICE | SLC18A1, SLC1A2, SLC29A1 | FFAR4 4867/4885MAPT 671/4885GAA 3122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.